Schedule of Basic and Diluted Net Income (Loss) Per Common Share |
The following table presents a reconciliation
of basic and diluted net income (loss) per common share:
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Net (loss) income per common share - basic: |
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income attributable to common shareholders |
|
$ |
(647,213 |
) |
|
$ |
(206,208 |
) |
|
$ |
(1,242,645 |
) |
|
$ |
2,853,035 |
|
Weighted average common shares outstanding – basic |
|
|
545,253,623 |
|
|
|
524,747,583 |
|
|
|
541,386,297 |
|
|
|
478,703,698 |
|
Net (loss) income per common share – basic |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per common share - diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income attributable to common shareholders - basic |
|
$ |
(647,213 |
) |
|
$ |
(206,208 |
) |
|
$ |
(1,242,645 |
) |
|
$ |
2,853,035 |
|
Add: preferred stock dividends |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
40,788 |
|
Add: interest of convertible debt |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
138,837 |
|
Numerator for (loss) income per common share – diluted |
|
$ |
(647,213 |
) |
|
$ |
(206,208 |
) |
|
$ |
(1,242,645 |
) |
|
$ |
3,032,660 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding – basic |
|
|
545,253,623 |
|
|
|
524,747,583 |
|
|
|
541,386,297 |
|
|
|
478,703,698 |
|
Add: dilutive shares related to: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible debt |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,145,833,333 |
|
Series B preferred |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
327,376,230 |
|
Series C preferred |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
403,380,750 |
|
Weighted average common shares outstanding – diluted |
|
|
545,253,623 |
|
|
|
524,747,583 |
|
|
|
541,386,297 |
|
|
|
2,355,294,011 |
|
Net (loss) income per common share – diluted |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
(0.00 |
) |
|
$ |
0.00 |
|
|
Schedule of Common Share Equivalents and Potentially Dilutive Securities |
As of September 30, 2024 and 2023, common share
equivalents and potentially dilutive securities consisted of the following:
|
|
September 30, |
|
|
|
2024 |
|
|
2023 |
|
Stock options |
|
|
6,770,698 |
|
|
|
8,445,698 |
|
Warrants |
|
|
33,200,000 |
|
|
|
34,000,000 |
|
Series B preferred stock |
|
|
357,819,360 |
|
|
|
327,376,230 |
|
Series C preferred stock |
|
|
400,468,718 |
|
|
|
403,380,750 |
|
Convertible debt |
|
|
1,215,950,855 |
|
|
|
1,145,833,333 |
|
|
|
|
2,014,209,631 |
|
|
|
1,919,036,011 |
|
|